{"disease":{"id":"brain-metastasis","name":"brain metastasis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06716775","title":"Tumor Treating Fields (TTF) in Combination with Stereotactic Radiosurgery(SRS) for Brain Metastases from Non-small Cell Lung Cancer.","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Jiangsu Healthy Life Innovation Medical Technology Co., Ltd","has_results":false},{"nct_id":"NCT01724801","title":"Icotinib or Whole Brain Irradiation in EGFR-mutant Lung Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":176,"lead_sponsor_name":"Guangdong Association of Clinical Trials","has_results":false},{"nct_id":"NCT06582940","title":"Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":168,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT06839560","title":"Evaluating the Efficacy and Safety of PD-L1 Monoclonal Antibody Combined with VEX Metronomic Chemotherapy and Concurrent or Delayed Radiotherapy in Patients with Advanced HER2-Negative Breast Cancer with Brain Metastasis","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":102,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT03223675","title":"Neurocognitive Impact and Dose-Effect Relationship of Hippocampal Avoidance During Whole Brain Radiotherapy Plus Simultaneous Integrated Boost - A Prospective Follow-up Study","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT06839547","title":"A Prospective, Multicenter, Observational Cohort Study to Evaluate the Efficacy and Safety of a Novel Anti-tumor Drug As a Radiosensitizer in Patients with Advanced Breast Cancer Brain Metastasis.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT02504788","title":"A Prospective Study of the Impact of Hippocampal Avoidance During Whole Brain Radiotherapy on Neurocognitive Function Decline","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT02448992","title":"Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT03257124","title":"Study of AZD9291 in NSCLC Patients Harboring T790M Mutation Who Failed EGFR TKI and With Brain and/or LMS","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT02013297","title":"Study of SBRT Efficacy on Intra and Extra -Cranial Tumors or Metastasis in Pediatrics Population (SBRT Pediatrics)","phase":"NA","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Centre Leon Berard","has_results":false},{"nct_id":"NCT04778800","title":"A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Henan Cancer Hospital","has_results":false},{"nct_id":"NCT07449481","title":"A Phase II Clinical Study of Utidelone and Bevacizumab With or Without Etoposide in Patients With Brain Metastases From Malignant Solid Tumors","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":56,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false},{"nct_id":"NCT07177950","title":"A Two-cohort Study of SHR-A1811 in the Treatment of HER2-positive Breast Cancer With Brain Metastases","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":51,"lead_sponsor_name":"Peking University Cancer Hospital & Institute","has_results":false},{"nct_id":"NCT00219297","title":"Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT07343479","title":"Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain Metastases","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":45,"lead_sponsor_name":"Zhejiang Cancer Hospital","has_results":false},{"nct_id":"NCT06462079","title":"Sacituzumab Govitecan Combined With Head Radiotherapy for Her2-negative Breast Cancer Brain Metastases","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":43,"lead_sponsor_name":"Guangzhou Medical University","has_results":false},{"nct_id":"NCT02681549","title":"Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer (NSCLC)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Yale University","has_results":true},{"nct_id":"NCT06282874","title":"Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":41,"lead_sponsor_name":"Guangdong Association of Clinical Trials","has_results":false},{"nct_id":"NCT04420598","title":"DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"MedSIR","has_results":true},{"nct_id":"NCT01445483","title":"Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain Metastases","phase":"","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06852001","title":"Efficacy of the RayerKnife X Stereotactic Radiotherapy System in the Treatment of Brain Metastases","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":34,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false},{"nct_id":"NCT06330870","title":"Brain Metastasis Development Mechanism in BCBM Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Samsung Medical Center","has_results":false},{"nct_id":"NCT06058988","title":"Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT05146219","title":"Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"TYK Medicines, Inc","has_results":false},{"nct_id":"NCT06374888","title":"Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastases","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":28,"lead_sponsor_name":"Convalife (Shanghai) Co., Ltd.","has_results":false},{"nct_id":"NCT06410040","title":"A Retrospective Study of the Efficacy and Safety of Lolatinib in ALK+ NSCLC Patients With Brain or Meningeal Metastasis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":28,"lead_sponsor_name":"Sichuan Cancer Hospital and Research Institute","has_results":false},{"nct_id":"NCT06210438","title":"SHR-A1921 Combined With Bevacizumab in Triple-negative Breast Cancer With Brain Metastases","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":24,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT07199413","title":"Allogeneic, Antigen-Presenting, GM-CSF-secreting, SV-BR-1-GM Whole Cell-Therapeutic Vaccine and Immunotherapy: A Phase I Pilot Safety and Feasibility Study for Solid Tumor Patients With CNS Metastases","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Medical College of Wisconsin","has_results":false},{"nct_id":"NCT00001328","title":"Gene Therapy for the Treatment of Brain Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"National Institute of Neurological Disorders and Stroke (NINDS)","has_results":false},{"nct_id":"NCT03190967","title":"T-DM1 Alone Versus T-DM1 and Metronomic Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases Following Stereotactic Radiosurgery","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT02279992","title":"Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain Metastases","phase":"EARLY_PHASE1","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Cedars-Sinai Medical Center","has_results":false},{"nct_id":"NCT03717142","title":"Feasibility of the LUM Imaging System for Detection of Cancer to the Brain","phase":"NA","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Lumicell, Inc.","has_results":false},{"nct_id":"NCT02580045","title":"Pharmacokinetics of Systemic Anti-Cancer Therapies in the Cerebrospinal Fluid (CSF) of Patients With Advanced Cancer","phase":"","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT03903640","title":"Optune Device - TT Field Plus Nivolumab and Ipilimumab for Melanoma With Brain Metastasis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Washington University School of Medicine","has_results":true},{"nct_id":"NCT02598427","title":"Intrathecal Pertuzumab and Trastuzumab in Patients With New Untreated Asymptomatic or Low Symptomatic Brain Metastasis in HER2 Positive Breast Cancer","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Kimberly Blackwell","has_results":false},{"nct_id":"NCT02328300","title":"FLT PET/MR for Evaluation of Pseudoprogression in Patients With Brain Lesions","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"UNC Lineberger Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT03203616","title":"Kadcyla In pAtients With bRAin Metastasis","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Jules Bordet Institute","has_results":false},{"nct_id":"NCT07011849","title":"Study of Lenvatinib Plus Pembrolizumab in IO Refractory mRCC Patients With Brain Metastases","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false}],"total":38},"guidelines":[],"source":"Drug Landscape verified database"}